Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma. [PDF]
Kurzinski KL, Zigler CK, Torok KS.
europepmc +1 more source
Objective: Biologic drugs are a potential treatment option in resistant cases of juvenile scleroderma. In this review, we aimed to examine previous studies regarding biologic drug use in pediatric patients with localized scleroderma and systemic ...
BATU AKAL, EZGİ DENİZ, Sener, Seher
core +1 more source
Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement. [PDF]
Sander L +5 more
europepmc +1 more source
Background. The aim of this project is to perform immunophenotyping of patients with JLS and healthy controls to assess dysregulated immunological pathways in JLS, and to identify biomarkers able to predict clinical features. Methods.
Società Italiana di Reumatologia
doaj
National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients. [PDF]
Branton SA +3 more
europepmc +1 more source
Case of localized scleroderma associated with osteomyelitis. [PDF]
We report a 4-year-old girl presenting with progressive linear scleroderma affecting the right leg. Biopsy specimen disclosed typical histopathological findings of localized scleroderma. Right leg magnetic resonance imaging (MRI) showed high signal areas
Ogawa, Fumihide +4 more
core
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles. [PDF]
Torok KS +7 more
europepmc +1 more source
Outcome measures and monitoring framework in juvenile systemic sclerosis: bridging routine care and clinical trials. [PDF]
Foeldvari I, Marrani E.
europepmc +1 more source
IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients. [PDF]
Takahashi T +5 more
europepmc +1 more source

